New drug combination therapy developed to treat leukemia
Thursday, April 18, 2013 - 12:54
in Biology & Nature
A new, pre-clinical study suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins. The effectiveness of the therapy lies in its ability to target a pro-survival cell signaling pathway known as PI3K/AKT/mTOR, upon which the leukemia cells have become dependent.